中西医结合治疗原发性痛经的临床证据
本研究作为ACE-iMed系列的一部分,系统检索并筛选了针对14个预定义临床问题的原发性痛经相关临床证据,纳入4部指南、37篇系统综述和178项随机对照试验。证据质量平均分超过量表最高分的50%,最常评估的干预为口服中药对比西药及针灸对比常规西医疗法。
要点
- 共纳入219条证据,包括4部指南、37篇系统综述和178项随机对照试验。
- 最常见比较为口服中药对比西药及针灸对比常规西医疗法。
核心结论
- 中药及中西医结合干预治疗原发性痛经的研究活跃,证据可供临床、患者、公众、政策制定者和研究者参考。
研究设计与样本
- 遵循ACE-iMed框架,系统筛选针对14个预定义临床问题的指南、系统综述和随机对照试验,检索时限自建库至2025年9月6日。
主要发现
- 共鉴定5062条记录,219条符合纳入标准:4部临床实践指南、37篇系统综述、178项随机对照试验。
关键数值与推荐
- 最常评估的对比为口服中药 versus 西药,以及针灸 versus 常规西医疗法。
临床怎么用
- 临床医生可访问http://www.aceimed.org获取整理后的原发性痛经证据,以支持循证实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary dysmenorrhea (PD), a common gynecological disorder, adversely affects the quality of life, mental health, and overall well-being of many young women. Given concerns about adverse effects of some Western medications, Chinese medicine (CM) and integrated Chinese-Western medicine (ICWM) approaches have gained attention. This study aims to systematically identify PD-related clinical evidence on CM and ICWM treatments, appraise and categorize the evidence by study design, and provide evidence summaries based on pre-defined clinical questions to inform evidence-based practice. METHODS: As part of the AI-empowered Clinical Evidence for Integrated Chinese-Western Medicine (ACE-iMed) series, this study followed the ACE-iMed framework to systematically screen and identify PD-related evidence addressing 14 pre-defined clinical questions. We focused on clinical practice guidelines/consensus statements, systematic reviews, and randomized controlled trials, and searched databases and relevant websites from inception through September 6, 2025. The overarching methods are detailed in the series' methodological paper; the key and PD-specific methods are described in this article. RESULTS: Of 5062 records identified, 219 met inclusion criteria: 4 clinical practice guidelines, 37 systematic reviews, and 178 randomized controlled trials. Almost eighty percent were published in Chinese. Mean quality assessment scores exceeded 50% of the maximum scale. The most frequently evaluated comparisons were oral Chinese herbal medicine versus Western medications and acupuncture versus conventional Western therapy. CONCLUSION: CM and ICWM interventions for PD are actively studied. Interest-holders, including clinicians, patients, the public, policymakers, and researchers, can access curated PD evidence (http://www.aceimed.org) to identify relevant studies and further support evidence-based research and practice.
引用
- Yu X, Wang Z, Ma Y, et al. Clinical evidence on integrated Chinese-Western medicine for primary dysmenorrhea. Integr Med Res. 2026. PMID: 42293428. doi:10.1016/j.imr.2026.101356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。